CTRI/2016/08/007190进行中（未招募）未知
Combination chemotherapy against visceral leishmaniasis: Comparative evaluation between miltefosine for 4 weeks and 2 weeks miltefosine combined with single dose liposomal amphotericin B in a tertiary care centre in Kolkata
Dr Rama Prosad Goswami0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with corroborative clinical history (prolonged fever not responding to antimalarials or antibiotics) and physical signs (anaemia, splenomegaly, hepatomegaly) with presence of parasites (LD bodies) confirmed by examination of Giemsa stained slides of splenic or bone marrow aspirates were enrolled into the study.
- •Confirmed visceral leishmaniasis patients who are fully informed about the risk of treatment and who signed the consent form themselves or by authorised relatives in their languages , will be included in the study group
排除标准
- •HIV positive individuals, Infant and children with body weight < 10Kgs, severe concurrent illnesses, receipt of any antileishmanial drugs or antifungal drugs in the previous 45 days, pregnancy and withdrawal of contraceptive measure. Patients with known hypersensitivity to the study drugs and those with diabetes, hypertension, or tuberculosis were also excluded. All patients with known heart, liver or kidney disease were excluded from the study. patients with renal function tests (serum creatinine) outside the normal range, liver function tests (transaminases) more than three times upper limit of the normal at study entry, Jaundice (bilirubin > 2.0mg/dL), Known hepatitis B or C positive, Platelet count less than 40,000/mm3, Prothrombin time 5 seconds or greater than normal range, Total WBC < 1,000/mm3, known alcohol or other drug abuse,concomitant chronic drug treatment eg for diabetes, hypertension, TB, HIV etc, concomitant drug usage for acute infection, eg malaria, pneumonia etc within the last 7 days were excluded.
研究者
相似试验
进行中（未招募）
1 期
Combined treatment of intraperitoneal chemotherapy after optimal interval surgery in advanced ovarian cancerOvarian cancer (OV-1)MedDRA version: 21.1Level: PTClassification code 10070907Term: Ovarian cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10070908Term: Ovarian cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2022-001107-41-ESFundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS)20
进行中（未招募）
1 期
Combined treatment of intraperitoneal chemotherapy after optimal interval surgery in advanced ovarian cancer. BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer).MedDRA version: 20.0Level: PTClassification code: 10033128Term: Ovarian cancer Class: 100000004864Ovarian cancerCTIS2022-502691-23-00Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia20
进行中（未招募）
不适用
Combined systemic an intrathecal chemotherapy with succeeding high dosis chemotherapy and autologous stem cell transplantation of patients with CNS relapses of agressive lymphomas. - NHL-ZNS-RezidivThe aim of the study is the prospective verification of effectiveness and compatibility of a systemic therapy with CNS passable cytostatics (high-dose Methotrexat and Ifosfamide, and high-dose Cytarabine and Thiothepa) combined with an intrathecal Depocyte therapy, followed by a High-dose dose chemotherapy with Carmustine, Thiothepa and Etoposid and an autologous stem cell transplantation.EUCTR2006-006516-30-DECharité-Universitätsmedizin Berlin
已完成
4 期
Combination drug therapy for fibromyalgia paiMusculoskeletal DiseasesOther soft tissue disorders, not elsewhere classifiedFibromyalgiaISRCTN20173707Queen's University (Canada)69
已完成
不适用
Combination therapy with a molecular target drug and iron chelator for the treatment of intractable hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000013461Department of Gastroenterology, Okayama University Hospital10